By definition, all patients with classical ‘seropositive’ RA have circulating anti-citrullinated protein antibodies (ACPA), also referred to by the test used for detecting them, the anti-cyclic citrullinated peptide (anti-CCP) test. Here, PRTN3 is linked to rheumatoid arthritis.